Terry P. Gould, Director, 10% Owner at Corvus Pharmaceuticals, Inc. (CRVS), bought 656,004 shares at $8.50 ($5.6M) on 2018-03-12, disclosed to the SEC on 2018-03-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.50 | 67,769 | $576K | 10.3% |
| 2 | $8.50 | 67,769 | $576K | 10.3% |
| 3 | $8.50 | 69,864 | $594K | 10.6% |
| 4 | $8.50 | 87,668 | $745K | 13.4% |
| 5 | $8.50 | 126,806 | $1.1M | 19.3% |
| 6 | $8.50 | 236,128 |
| $2.0M |
| 36.0% |
| Total | $8.50 avg | 656,004 | $5.6M | 100% |
| Filing → |
| CRVS | BUY | 2016-03-29 | $3.0M | — | Filing → |